Lu Gao
- Molecular Biology top 5%
- Cancer Research top 2%
- Cardiology and Cardiovascular Medicine top 5%
- Pulmonary and Respiratory Medicine top 10%
- Epidemiology top 10%
- Co-authors
- Lili XiaoYanzhou ZhangLeiming WuYuzhou LiuH A AshtonR A P ScottSimon G. ThompsonMartin Buxton
- Topics
- Cardiac Fibrosis and Remodeling (17 papers)Signaling Pathways in Disease (12 papers)MicroRNA in disease regulation (11 papers)
- Journals
- Nature CommunicationsSHILAP Revista de lepidopterologíaPLoS ONE
- Partner nations
- ChinaUnited StatesMontenegro
In The Last Decade
Lu Gao
133 papers receiving 2.8k citations
Peers
Comparison fields: 5 of 133
- Molecular Biology 1.4k
- Cancer Research 712
- Cardiology and Cardiovascular Medicine 533
- Pulmonary and Respiratory Medicine 341
- Epidemiology 257
Countries citing papers authored by Lu Gao
This map shows the geographic impact of Lu Gao's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Lu Gao with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Lu Gao more than expected).
Fields of papers citing papers by Lu Gao
This network shows the impact of papers produced by Lu Gao. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Lu Gao. The network helps show where Lu Gao may publish in the future.
Co-authorship network of co-authors of Lu Gao
This figure shows the co-authorship network connecting the top 25 collaborators of Lu Gao. A scholar is included among the top collaborators of Lu Gao based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Lu Gao. Lu Gao is excluded from the visualization to improve readability, since they are connected to all nodes in the network.
All Works
| # | Work | Indexed citations |
|---|---|---|
| 1 | 5 | |
| 2 | 2 | |
| 3 | 3 | |
| 4 | 3 | |
| 5 | 0 | |
| 6 | 0 | |
| 7 | 13 | |
| 8 | 0 | |
| 9 | 3 | |
| 10 | 19 | |
| 11 | 6 | |
| 12 | 11 | |
| 13 | 2 | |
| 14 | 12 | |
| 15 | 2 | |
| 16 | 49 | |
| 17 | Identification and characterization of the Bombyx mori myosin II essential light chain and its effect in BmNPV infection | 1 |
| 18 | 28 | |
| 19 | 32 | |
| 20 | 22 |
About Lu Gao
Lu Gao is a scholar working on Cancer Research, Cardiology and Cardiovascular Medicine and Molecular Biology, having authored 143 papers that have together received 2.8k indexed citations. Recurring topics across this work include Cardiac Fibrosis and Remodeling (17 papers), Signaling Pathways in Disease (12 papers) and MicroRNA in disease regulation (11 papers). The work is most often cited by research in Cancer Research (712 citations), Cardiology and Cardiovascular Medicine (533 citations) and Molecular Biology (1.4k citations). Lu Gao has collaborated with scholars based in China, United States and Montenegro. Frequent co-authors include Lili Xiao, Yanzhou Zhang, Leiming Wu, Yuzhou Liu, H A Ashton, R A P Scott, Simon G. Thompson, Martin Buxton, Cui Liang and Rui Yao. Their work appears in journals such as Nature Communications, SHILAP Revista de lepidopterología and PLoS ONE.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.